Similar articles

• Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.

  Pool V, Braun MM, Kelso JM, Mootrey G, Chen RT, Yunginger JW, Jacobson RM, Gargiullo PM; VAERS Team. US Vaccine Adverse Event Reporting System. Pool V, et al. Pediatrics. 2002 Dec;110(6):e71. doi: 10.1542/peds.110.6.e71. Pediatrics. 2002. PMID: 12456938
• Systemic allergic reactions to gelatin included in vaccines as a stabilizer.

  Sakaguchi M, Inouye S. Sakaguchi M, et al. Jpn J Infect Dis. 2000 Oct;53(5):189-95. Jpn J Infect Dis. 2000. PMID: 11135703 Review.
• Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy.

  Kuno-Sakai H, Kimura M. Kuno-Sakai H, et al. Biologicals. 2003 Dec;31(4):245-9. doi: 10.1016/s1045-1056(03)00063-0. Biologicals. 2003. PMID: 14624794
• A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.

  Marlow R, Kuriyakose S, Mesaros N, Han HH, Tomlinson R, Faust SN, Snape MD, Pollard AJ, Finn A. Marlow R, et al. Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22. Vaccine. 2018. PMID: 29576304 Clinical Trial.
• [Epidemiology of food allergy (its comparison between Japan and other countries)].

  Ebisawa M. Ebisawa M. Arerugi. 2007 Jan;56(1):10-7. Arerugi. 2007. PMID: 17272952 Review. Japanese. No abstract available.